$NKTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEKTAR THERAPEUTICS. Get notifications about new insider transactions in NEKTAR THERAPEUTICS for free.
Page: < prev 1 ... 7 8 9 10 11 12 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 14 2005 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | A | 18.08 | 25,000 | 452,000 | 850,464 | |
Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | A | 0.01 | 10,000 | 100 | 0 | |
Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | A | 18.54 | 20,000 | 370,800 | 0 | |
Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Option Exercise | A | 0.01 | 10,000 | 100 | 0 | |
Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Option Exercise | A | 18.54 | 20,000 | 370,800 | 0 | |
Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | A | 0.01 | 10,000 | 100 | 0 | |
Feb 11 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | A | 18.54 | 20,000 | 370,800 | 0 | |
Jan 19 2005 | NKTR | NEKTAR THERAPEUTIC ... | Elam Nevan C | General Counsel and ... | Option Exercise | A | 18.61 | 80,000 | 1,488,800 | 0 | |
Jan 18 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | M | 4.56 | 31,600 | 144,175 | 0 | |
Jan 18 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Buy | M | 18.61 | 31,600 | 588,076 | 534,878 | 503.3 K to 534.9 K (+6.28 %) |
Jan 10 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Gift | G | 0.00 | 4,030 | 0 | 503,278 | 507.3 K to 503.3 K (-0.79 %) |
Jan 10 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | M | 4.56 | 42,800 | 195,275 | 0 | |
Jan 10 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Buy | M | 19.19 | 42,800 | 821,332 | 118,112 | 75.3 K to 118.1 K (+56.83 %) |
Jan 05 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.43 | 7,000 | 38,003 | 78,500 | |
Jan 05 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 20.06 | 7,000 | 140,420 | 25,000 | 32 K to 25 K (-21.87 %) |
Jan 05 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.43 | 7,000 | 38,003 | 25,000 | 18 K to 25 K (+38.89 %) |
Dec 16 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 19.42 | 3,400 | 66,033 | 2,211 | 5.6 K to 2.2 K (-60.60 %) |
Dec 01 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.43 | 1,500 | 8,144 | 85,500 | |
Dec 01 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | S | 20.00 | 1,500 | 30,000 | 25,000 | 23.5 K to 25 K (+6.38 %) |
Dec 01 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.43 | 1,500 | 8,144 | 25,000 | 23.5 K to 25 K (+6.38 %) |
Sep 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 12.91 | 12,500 | 161,375 | 152,500 | |
Sep 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | PERELMAN MELVIN | Director | Option Exercise | A | 12.91 | 12,500 | 161,375 | 147,500 | |
Sep 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | LERNER IRWIN | Director | Option Exercise | A | 12.91 | 12,500 | 161,375 | 137,500 | |
Sep 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 12.91 | 12,500 | 161,375 | 92,500 | |
Sep 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 12.91 | 12,500 | 161,375 | 49,875 | |
Sep 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | BROWN MICHAEL A/CA | Director | Option Exercise | A | 12.91 | 12,500 | 161,375 | 65,000 | |
Jun 18 2004 | NKTR | NEKTAR THERAPEUTIC ... | LERNER IRWIN | Director | Option Exercise | A | 18.29 | 30,000 | 548,700 | 125,000 | |
Jun 18 2004 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 18.29 | 30,000 | 548,700 | 80,000 | |
Jun 14 2004 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Gift | G | 0.00 | 9,250 | 0 | 75,312 | 84.6 K to 75.3 K (-10.94 %) |
Jun 18 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | A | 18.29 | 30,000 | 548,700 | 405,200 | |
Mar 10 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 14.25 | 26,008 | 370,614 | 816,021 | |
Mar 10 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 11.55 | 6,808 | 78,632 | 816,021 | |
Mar 10 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 14.25 | 26,008 | 370,614 | 221,654 | 195.6 K to 221.7 K (+13.29 %) |
Mar 10 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 11.55 | 6,808 | 78,632 | 221,654 | 214.8 K to 221.7 K (+3.17 %) |
Mar 10 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 22.69 | 32,816 | 744,677 | 221,654 | 254.5 K to 221.7 K (-12.90 %) |
Mar 10 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 22.69 | 23,784 | 539,718 | 221,654 | 245.4 K to 221.7 K (-9.69 %) |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 11.55 | 4,567 | 52,749 | 848,837 | |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 9.31 | 30,800 | 286,825 | 848,837 | |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 6.12 | 9,704 | 59,388 | 848,837 | |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 11.55 | 4,567 | 52,749 | 245,438 | 240.9 K to 245.4 K (+1.90 %) |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 9.31 | 30,800 | 286,825 | 245,438 | 214.6 K to 245.4 K (+14.35 %) |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 6.12 | 9,704 | 59,388 | 245,438 | 235.7 K to 245.4 K (+4.12 %) |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 21.87 | 45,071 | 985,482 | 245,438 | 290.5 K to 245.4 K (-15.51 %) |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 21.87 | 54,929 | 1,201,028 | 245,438 | 300.4 K to 245.4 K (-18.29 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 21.73 | 50,000 | 1,086,500 | 743,904 | 793.9 K to 743.9 K (-6.30 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 21.73 | 50,000 | 1,086,500 | 711,416 | 761.4 K to 711.4 K (-6.57 %) |
Mar 09 2004 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 24.06 | 21,800 | 524,508 | 84,562 | 106.4 K to 84.6 K (-20.50 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | A | 19.55 | 100,000 | 1,955,000 | 1,498,244 | |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.07 | 19,099 | 421,460 | 56,362 | 75.5 K to 56.4 K (-25.31 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.11 | 5,901 | 130,471 | 56,362 | 62.3 K to 56.4 K (-9.48 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 21.86 | 25,000 | 546,623 | 56,362 | 81.4 K to 56.4 K (-30.73 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Grant | A | 0.01 | 100,000 | 1,000 | 100,000 | 0 to 100 K |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | A | 19.55 | 33,333 | 651,660 | 893,908 | |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 6.12 | 15,738 | 96,317 | 893,908 | |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 8.06 | 538 | 4,338 | 893,908 | |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 5.06 | 48,391 | 244,979 | 893,908 | |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Grant | A | 0.01 | 16,666 | 167 | 300,367 | 283.7 K to 300.4 K (+5.87 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 21.95 | 100,000 | 2,195,000 | 300,367 | 400.4 K to 300.4 K (-24.98 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 6.12 | 15,738 | 96,317 | 300,367 | 284.6 K to 300.4 K (+5.53 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 8.06 | 538 | 4,338 | 300,367 | 299.8 K to 300.4 K (+0.18 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 5.06 | 48,391 | 244,979 | 300,367 | 252 K to 300.4 K (+19.20 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.46 | 5,800 | 130,268 | 507,308 | 513.1 K to 507.3 K (-1.13 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.40 | 300 | 6,720 | 507,308 | 507.6 K to 507.3 K (-0.06 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.30 | 100 | 2,230 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.29 | 200 | 4,458 | 507,308 | 507.5 K to 507.3 K (-0.04 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.16 | 100 | 2,216 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.15 | 300 | 6,645 | 507,308 | 507.6 K to 507.3 K (-0.06 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.14 | 200 | 4,428 | 507,308 | 507.5 K to 507.3 K (-0.04 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.12 | 100 | 2,212 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.10 | 4,600 | 101,660 | 507,308 | 511.9 K to 507.3 K (-0.90 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.06 | 1,200 | 26,472 | 507,308 | 508.5 K to 507.3 K (-0.24 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.03 | 400 | 8,812 | 507,308 | 507.7 K to 507.3 K (-0.08 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.01 | 100 | 2,201 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.00 | 6,600 | 145,200 | 507,308 | 513.9 K to 507.3 K (-1.28 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.46 | 5,800 | 130,268 | 507,308 | 513.1 K to 507.3 K (-1.13 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.40 | 300 | 6,720 | 507,308 | 507.6 K to 507.3 K (-0.06 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.30 | 100 | 2,230 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.29 | 200 | 4,458 | 507,308 | 507.5 K to 507.3 K (-0.04 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.16 | 100 | 2,216 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.15 | 300 | 6,645 | 507,308 | 507.6 K to 507.3 K (-0.06 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.14 | 200 | 4,428 | 507,308 | 507.5 K to 507.3 K (-0.04 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.12 | 100 | 2,212 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.10 | 4,600 | 101,660 | 507,308 | 511.9 K to 507.3 K (-0.90 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.06 | 1,200 | 26,472 | 507,308 | 508.5 K to 507.3 K (-0.24 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.03 | 400 | 8,812 | 507,308 | 507.7 K to 507.3 K (-0.08 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.01 | 100 | 2,201 | 507,308 | 507.4 K to 507.3 K (-0.02 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.00 | 6,600 | 145,200 | 507,308 | 513.9 K to 507.3 K (-1.28 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.06 | 3,000 | 15,188 | 87,000 | |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 21.80 | 1,000 | 21,800 | 25,000 | 26 K to 25 K (-3.85 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 21.97 | 2,000 | 43,940 | 25,000 | 27 K to 25 K (-7.41 %) |
Mar 08 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.06 | 3,000 | 15,188 | 25,000 | 22 K to 25 K (+13.64 %) |
Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.70 | 17,981 | 354,226 | 793,904 | 811.9 K to 793.9 K (-2.21 %) |
Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.70 | 17,981 | 354,226 | 761,416 | 779.4 K to 761.4 K (-2.31 %) |
Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Grant | A | 0.01 | 25,000 | 250 | 25,000 | 0 to 25 K |
Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Grant | A | 0.01 | 25,000 | 250 | 25,000 | 0 to 25 K |
Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Grant | A | 0.01 | 25,000 | 250 | 25,000 | 0 to 25 K |
Mar 03 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Option Exercise | A | 19.05 | 10,000 | 190,500 | 184,000 | |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 5.06 | 3,213 | 16,266 | 925,242 | |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 19.90 | 1,887 | 37,551 | 319,034 | 320.9 K to 319 K (-0.59 %) |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 19.90 | 3,213 | 63,939 | 319,034 | 322.2 K to 319 K (-1.00 %) |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 5.06 | 3,213 | 16,266 | 319,034 | 315.8 K to 319 K (+1.02 %) |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 5.06 | 3,213 | 16,266 | 925,242 | |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 19.90 | 1,887 | 37,551 | 319,034 | 320.9 K to 319 K (-0.59 %) |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 19.90 | 3,213 | 63,939 | 319,034 | 322.2 K to 319 K (-1.00 %) |
Feb 23 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Buy | M | 5.06 | 3,213 | 16,266 | 319,034 | 315.8 K to 319 K (+1.02 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.85 | 150 | 2,978 | 811,885 | 812 K to 811.9 K (-0.02 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.85 | 438 | 8,694 | 811,885 | 812.3 K to 811.9 K (-0.05 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.84 | 50 | 992 | 811,885 | 811.9 K to 811.9 K (-0.01 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.82 | 50 | 991 | 811,885 | 811.9 K to 811.9 K (-0.01 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.81 | 300 | 5,943 | 811,885 | 812.2 K to 811.9 K (-0.04 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.80 | 6,494 | 128,581 | 811,885 | 818.4 K to 811.9 K (-0.79 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.78 | 2,700 | 53,406 | 811,885 | 814.6 K to 811.9 K (-0.33 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.77 | 2,300 | 45,471 | 811,885 | 814.2 K to 811.9 K (-0.28 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.72 | 150 | 2,958 | 811,885 | 812 K to 811.9 K (-0.02 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.70 | 32,350 | 637,295 | 811,885 | 844.2 K to 811.9 K (-3.83 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.85 | 150 | 2,978 | 779,397 | 779.5 K to 779.4 K (-0.02 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.85 | 437 | 8,674 | 779,397 | 779.8 K to 779.4 K (-0.06 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.84 | 50 | 992 | 779,397 | 779.4 K to 779.4 K (-0.01 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.82 | 50 | 991 | 779,397 | 779.4 K to 779.4 K (-0.01 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.81 | 300 | 5,943 | 779,397 | 779.7 K to 779.4 K (-0.04 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.80 | 6,494 | 128,581 | 779,397 | 785.9 K to 779.4 K (-0.83 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.78 | 2,700 | 53,406 | 779,397 | 782.1 K to 779.4 K (-0.35 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.77 | 2,300 | 45,471 | 779,397 | 781.7 K to 779.4 K (-0.29 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.72 | 150 | 2,958 | 779,397 | 779.5 K to 779.4 K (-0.02 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.70 | 32,350 | 637,295 | 779,397 | 811.7 K to 779.4 K (-3.99 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 20.00 | 1,900 | 38,000 | 856,867 | 858.8 K to 856.9 K (-0.22 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.97 | 1,250 | 24,963 | 856,867 | 858.1 K to 856.9 K (-0.15 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.95 | 350 | 6,983 | 856,867 | 857.2 K to 856.9 K (-0.04 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.91 | 300 | 5,973 | 856,867 | 857.2 K to 856.9 K (-0.03 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.91 | 1,600 | 31,856 | 856,867 | 858.5 K to 856.9 K (-0.19 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.89 | 175 | 3,481 | 856,867 | 857 K to 856.9 K (-0.02 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.89 | 250 | 4,973 | 856,867 | 857.1 K to 856.9 K (-0.03 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.89 | 350 | 6,962 | 856,867 | 857.2 K to 856.9 K (-0.04 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.72 | 4,000 | 78,880 | 856,867 | 860.9 K to 856.9 K (-0.46 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.71 | 1,450 | 28,580 | 856,867 | 858.3 K to 856.9 K (-0.17 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.70 | 4,246 | 83,646 | 856,867 | 861.1 K to 856.9 K (-0.49 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 20.00 | 1,900 | 38,000 | 824,378 | 826.3 K to 824.4 K (-0.23 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.97 | 1,250 | 24,963 | 824,378 | 825.6 K to 824.4 K (-0.15 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.95 | 350 | 6,983 | 824,378 | 824.7 K to 824.4 K (-0.04 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.91 | 300 | 5,973 | 824,378 | 824.7 K to 824.4 K (-0.04 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.91 | 1,600 | 31,856 | 824,378 | 826 K to 824.4 K (-0.19 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.89 | 175 | 3,481 | 824,378 | 824.6 K to 824.4 K (-0.02 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.89 | 250 | 4,973 | 824,378 | 824.6 K to 824.4 K (-0.03 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.89 | 350 | 6,962 | 824,378 | 824.7 K to 824.4 K (-0.04 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.72 | 4,000 | 78,880 | 824,378 | 828.4 K to 824.4 K (-0.48 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.71 | 1,450 | 28,580 | 824,378 | 825.8 K to 824.4 K (-0.18 %) |
Feb 20 2004 | NKTR | NEKTAR THERAPEUTIC ... | HARRIS J MILTON | President of Nektar ... | Sell | S | 19.70 | 4,245 | 83,627 | 824,378 | 828.6 K to 824.4 K (-0.51 %) |
Feb 12 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 5.06 | 4,396 | 22,255 | 928,455 | |
Feb 12 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 4.56 | 40,896 | 186,588 | 928,455 | |
Feb 12 2004 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 19.98 | 7,400 | 147,852 | 320,921 | 328.3 K to 320.9 K (-2.25 %) |